© 2022 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
April 25, 2022
An expert reproductive endocrinologist explores the future treatment landscape for patients with endometriosis.
Dr Robert N. Taylor provides insight on emerging treatments and integrative therapies on the horizon with elagolix as well as real-world challenges using elagolix for endometriosis management.
Robert N. Taylor, MD, PhD, discusses key findings from clinical trial data on the dosing, pain relief profile, and adverse events of elagolix for patients with endometriosis.
An expert reproductive endocrinologist comments on the patient selection of aromatase inhibitors and the role of selective estrogen receptor modulators (SERMs) for endometriosis treatment.
Dr Robert N. Taylor examines the use of GnRH receptor antagonists, including elagolix, for the management of endometriosis.
Robert N. Taylor, MD, PhD, reviews first- and second-line therapies for the treatment of endometriosis.